LMAT Lemaitre Vascular Inc

Price (delayed)

$66.36

Market cap

$1.48B

P/E Ratio

48.79

Dividend/share

$0.58

EPS

$1.36

Enterprise value

$1.48B

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, ...

Highlights
LMAT's net income is up by 46% year-on-year and by 10% since the previous quarter
The EPS has grown by 45% YoY and by 11% from the previous quarter
The P/E is 20% more than the 5-year quarterly average of 40.6 but 2.4% less than the last 4 quarters average of 50.0
The company's debt rose by 15% YoY and by 13% QoQ

Key stats

What are the main financial stats of LMAT
Market
Shares outstanding
22.34M
Market cap
$1.48B
Enterprise value
$1.48B
Valuations
Price to book (P/B)
4.96
Price to sales (P/S)
7.62
EV/EBIT
37.42
EV/EBITDA
30.15
EV/Sales
7.63
Earnings
Revenue
$193.48M
EBIT
$39.48M
EBITDA
$48.99M
Free cash flow
$29.49M
Per share
EPS
$1.36
Free cash flow per share
$1.33
Book value per share
$13.38
Revenue per share
$8.71
TBVPS
$10.76
Balance sheet
Total assets
$346.78M
Total liabilities
$48.88M
Debt
$19.1M
Equity
$297.9M
Working capital
$164.72M
Liquidity
Debt to equity
0.06
Current ratio
6.51
Quick ratio
4.36
Net debt/EBITDA
-0.11
Margins
EBITDA margin
25.3%
Gross margin
65.7%
Net margin
15.6%
Operating margin
19%
Efficiency
Return on assets
9.1%
Return on equity
10.5%
Return on invested capital
20.6%
Return on capital employed
12.5%
Return on sales
20.4%
Dividend
Dividend yield
0.87%
DPS
$0.58
Payout ratio
42.6%

LMAT stock price

How has the Lemaitre Vascular stock price performed over time
Intraday
-1.25%
1 week
-1.46%
1 month
-6.61%
1 year
28.65%
YTD
16.91%
QTD
16.91%

Financial performance

How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$193.48M
Gross profit
$127.05M
Operating income
$36.71M
Net income
$30.11M
Gross margin
65.7%
Net margin
15.6%
LMAT's net income is up by 46% year-on-year and by 10% since the previous quarter
The operating income has grown by 37% YoY and by 10% from the previous quarter
The company's net margin rose by 22% YoY and by 6% QoQ
The company's gross profit rose by 21% YoY and by 6% QoQ

Growth

What is Lemaitre Vascular's growth rate over time

Valuation

What is Lemaitre Vascular stock price valuation
P/E
48.79
P/B
4.96
P/S
7.62
EV/EBIT
37.42
EV/EBITDA
30.15
EV/Sales
7.63
The EPS has grown by 45% YoY and by 11% from the previous quarter
The P/E is 20% more than the 5-year quarterly average of 40.6 but 2.4% less than the last 4 quarters average of 50.0
LMAT's price to book (P/B) is 13% higher than its 5-year quarterly average of 4.4 and 10% higher than its last 4 quarters average of 4.5
The equity has grown by 11% YoY and by 3.2% from the previous quarter
Lemaitre Vascular's revenue has increased by 20% YoY and by 4.3% from the previous quarter
The P/S is 19% above the 5-year quarterly average of 6.4 and 7% above the last 4 quarters average of 7.1

Efficiency

How efficient is Lemaitre Vascular business performance
The ROE has grown by 33% YoY and by 7% from the previous quarter
Lemaitre Vascular's return on assets has increased by 32% YoY and by 7% QoQ
LMAT's ROIC is up by 21% year-on-year and by 5% since the previous quarter
The ROS has grown by 20% YoY and by 5% from the previous quarter

Dividends

What is LMAT's dividend history
DPS
$0.58
Dividend yield
0.87%
Payout ratio
42.6%
Recent dividends

Financial health

How did Lemaitre Vascular financials performed over time
The company's total liabilities rose by 16% YoY and by 8% QoQ
The company's total assets rose by 12% YoY and by 3.8% QoQ
The company's debt is 94% lower than its equity
The company's debt rose by 15% YoY and by 13% QoQ
The equity has grown by 11% YoY and by 3.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.